| _version_ |
1811198344934981632
|
| collection |
DOAJ
|
| first_indexed |
2024-04-12T01:28:45Z
|
| format |
Article
|
| id |
doaj.art-9abd02efa40341449969165dfc559884
|
| institution |
Directory Open Access Journal
|
| issn |
2051-1426
|
| language |
English
|
| last_indexed |
2024-04-12T01:28:45Z
|
| publishDate |
2022-10-01
|
| publisher |
BMJ Publishing Group
|
| record_format |
Article
|
| series |
Journal for ImmunoTherapy of Cancer
|
| spelling |
doaj.art-9abd02efa40341449969165dfc5598842022-12-22T03:53:33ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262022-10-01101010.1136/jitc-2021-004022corr1Correction: CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapyhttps://jitc.bmj.com/content/10/10/e004022corr1.full
|
| spellingShingle |
Correction: CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy
Journal for ImmunoTherapy of Cancer
|
| title |
Correction: CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy
|
| title_full |
Correction: CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy
|
| title_fullStr |
Correction: CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy
|
| title_full_unstemmed |
Correction: CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy
|
| title_short |
Correction: CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy
|
| title_sort |
correction cd4 t cell epitope based heterologous prime boost vaccination potentiates anti tumor immunity and pd 1 pd l1 immunotherapy
|
| url |
https://jitc.bmj.com/content/10/10/e004022corr1.full
|